Cancer Prevention Group Blog

Cancer Prevention Group Blog

Research Today, Cancer Prevention Tomorrow

cervical cancer

HPV Vaccination in Japan: The Journey to Resuming a National Immunisation Programme

May 27, 2022 Jane Rigney 0

This post was written by guest author Maddie Rose Baker. Maddie is an International Journalism Master’s student at City, University of London. She also is a […]

‘The tragedy of thousands who need not die’: A history of cervical screening in England Part I

May 13, 2022 Jane Rigney 0

This post was written by guest author Scarlett Dargan. Scarlett read History at Churchill College, Cambridge. She is now studying for a master’s in journalism at […]

Supporting women through a cancer diagnosis: an interview with Rachel Baker

February 4, 2022 Jane Rigney 0

This interview was conducted by Maddie Baker, a postgraduate student at City University studying MA International Journalism. Rachel Baker became the first Macmillan funded Clinical […]

Cancer Prevention Group’s 2021 Christmas reading list

December 19, 2021 Jamie Doorbar 0

It’s that time of year again – to sit back, relax, and get stuck into one of our papers over the festive period! Below are […]

HPV Vaccination, past & future: An interview with Judith Breuer

November 19, 2021 Jane Rigney 0

Professor Judith Breuer FMedSci is Professor of Virology and Co-Director of the Division of Infection and Immunity at UCL, and Consultant Clinical Virologist at Great […]

From assessing attitudes to a hypothetical HPV vaccine to seeing the real impact on cancer rates: reflections on 15 years of HPV vaccine behavioural science

November 12, 2021 Jane Rigney 0

This post was written by Dr Jo Waller & Dr Laura Marlow. Jo is a reader in cancer behavioural science & has a particular interest […]

HPV Vaccination, from theory to practice: An interview with Margaret Stanley

November 4, 2021 Jamie Doorbar 1

Prof Margaret Stanley is the Emeritus Professor of Epithelial Biology in the Division of Cellular and Molecular Pathology at the University of Cambridge, Department of […]

Cancer Prevention Group’s 2020 Christmas reading list

December 21, 2020 Jamie Doorbar 0

Following the success of our 2019 reading list (available here) we’ve decided to put together a list of 25 publications to celebrate the cancer prevention […]

Achieving cervical cancer elimination requires collective action from civil society

November 16, 2020 Jane Rigney 0

In her previous blog, Rose Brade, policy advisor for Cancer Research UK’s international cervical cancer prevention programme, wrote about her personal experiences with vaccine hesitancy […]

Five minutes with: Dr Mona Saraiya

September 18, 2020 Jane Rigney 0

Our “Five Minutes With” series seeks to discover what are the habits, inspirations and obstacles that have shaped the careers of leading cancer researchers and […]

Finding the optimal HPV test for primary screening and triage in Latin America

September 11, 2020 Jane Rigney 0

In this blog, we speak to Dr Maribel Almonte Pacheco, Prevention and Implementation Group Head at IARC. Dr Almonte is the chief investigator on the […]

Posts navigation

1 2 »

Welcome to the King’s Cancer Prevention blog

This blog is supported by the Cancer Research UK Cambridge Centre Early Detection Programme

Cancer Prevention: About us

We are a group of epidemiologists and population researchers studying the causes of or early events in the development of cancer. Our aim is to be able to interfere and prevent cancer or diagnose it whilst still easy to treat.

Contact us at cancerprev@kcl.ac.uk

Follow us on Social Media

TWITTER FEED

Tweets by CancerPrev_KCL

Latest Posts, Tags & Comments
  • HPV Vaccination in Japan: The Journey to Resuming a National Immunisation Programme
  • ‘The tragedy of thousands who need not die’: A history of cervical screening in England Part I
  • PODCAST: Remote Consultations in Primary Care
  • What are women’s views of personalised breast cancer risk assessment and risk-stratified breast screening?
  • Building back better: How can cancer screening & prevention level up?
  • Pride in Research: The legacy of erasure and the future of LGBT+ inclusive trials
  • Will remote consultations help us to achieve earlier diagnosis of cancer?
  • Supporting women through a cancer diagnosis: an interview with Rachel Baker
  • Building informed consent – the importance of trust and transparency in safe health data sharing practices
  • There are things we can do to make increased cervical screening intervals more acceptable
Barrett’s oesophagus Best 3 Breast cancer screening cancer prevention cancer screening cervical cancer cervical screening Clinical research network COVID-19 Cytosponge™ ethics five minutes with HPV HPV primary screening HPV vaccination mammography medical research Oesophageal cancer prevention public health public policy screening sensitivity Upper GI Women in Science
  • What are women’s views of personalised breast cancer risk assessment and risk-stratified breast screening? – Cancer Prevention Group Blog: […] Autumn, we posted a blog that outlined why the introduction of risk-stratification to the NHS Breast Screening Programme is…
  • Building back better: How can cancer screening & prevention level up? – Cancer Prevention Group Blog: […] In the wake of the COVID-19 pandemic, the current government has committed to ‘building back better’ and ‘levelling up’…
  • Pride in Research: The legacy of erasure and the future of LGBT+ inclusive trials – Cancer Prevention Group Blog: […] Much like other marginalised communities, there is a historical mistrust of health institutions in the queer community, as a…
Meta
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Copyright © 2022 | WordPress Theme by MH Themes